Drug Manufacturers - Specialty & Generic IPOs

Performance analysis and trends for 11 IPOs in the drug manufacturers - specialty & generic sector.

Total IPOs

11

Avg Return

-41.6%

Success Rate

9.1%

1 of 11 positive

Total Market Cap

$18.3B

Recent IPOs (2024+)

CompanyDateIPO PriceCurrentReturnMarket Cap
APUS
Apimeds Pharmaceuticals US, Inc.
5/9/2025$4.00$1.88-53.0%$2.4M
ZYBT
Zhengye Biotechnology Holding Limited
1/7/2025$4.00$0.92-76.9%$43.7M
GELS
Gelteq Limited
10/29/2024$4.00$0.67-83.3%$7.2M
BIOA
BioAge Labs, Inc.
9/26/2024$18.00$17.44-3.1%$774.3M

Best Performers

CompanyReturnIPO Date
RGC
Regencell Bioscience Holdings Limited
+205.8%7/16/2021
BIOA
BioAge Labs, Inc.
-3.1%9/26/2024
AMLX
Amylyx Pharmaceuticals, Inc.
-14.2%1/7/2022
APUS
Apimeds Pharmaceuticals US, Inc.
-53.0%5/9/2025
ZYBT
Zhengye Biotechnology Holding Limited
-76.9%1/7/2025

Worst Performers

CompanyReturnIPO Date
LSDIF
Lucy Scientific Discovery Inc.
-100.0%2/9/2023
EVO
Evotec SE
-88.6%11/4/2021
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
-87.1%8/31/2022
GELS
Gelteq Limited
-83.3%10/29/2024
TKNO
Alpha Teknova, Inc.
-79.6%6/25/2021

Activity by Year

2025
2 IPOs
-65.0%
2024
2 IPOs
-43.2%
2023
1 IPOs
-100.0%
2022
2 IPOs
-50.6%
2021
4 IPOs
-10.0%

All Drug Manufacturers - Specialty & Generic IPOs

CompanyDateIPO PriceCurrentReturnExchange
APUS
Apimeds Pharmaceuticals US, Inc.
5/9/2025$4.00$1.88-53.0%NYSE American
ZYBT
Zhengye Biotechnology Holding Limited
1/7/2025$4.00$0.92-76.9%NASDAQ
GELS
Gelteq Limited
10/29/2024$4.00$0.67-83.3%NASDAQ
BIOA
BioAge Labs, Inc.
9/26/2024$18.00$17.44-3.1%NASDAQ
LSDIF
Lucy Scientific Discovery Inc.
2/9/2023$4.00$0.00-100.0%OTC Pink
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
8/31/2022$8.13$1.05-87.1%NASDAQ
AMLX
Amylyx Pharmaceuticals, Inc.
1/7/2022$19.00$16.31-14.2%NASDAQ
EVO
Evotec SE
11/4/2021$26.16$2.98-88.6%NASDAQ
BFRI
Biofrontera Inc.
10/29/2021$5.00$1.12-77.6%NASDAQ
RGC
Regencell Bioscience Holdings Limited
7/16/2021$9.50$29.05+205.8%NASDAQ
TKNO
Alpha Teknova, Inc.
6/25/2021$16.00$3.27-79.6%NASDAQ